Last updated on October 2017

Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium


Brief description of study

The purpose of the trial is to investigate if the use of inhaled colistimethate sodium administered twice daily for 12 months delays the time to the first pulmonary exacerbation compared to placebo in subjects with non-cystic fibrosis (CF) bronchiectasis chronically infected with P. aeruginosa

Clinical Study Identifier: NCT03093974

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Michela Meroni, MSc

Az Delta Pneumology
Roeselare, Belgium
  Connect »

Michela Meroni, MSc

Pneumologische Praxis am Schloss Charlottenburg
Berlin, Germany
  Connect »

Michela Meroni, MSc

RCMS
Berlin, Germany
  Connect »

Michela Meroni, MSc

Studienzentrum Dr Keller
Frankfurt am Main, Germany
  Connect »

Michela Meroni, MSc

IFP Pneumologie
Frankfurt, Germany
  Connect »

Michela Meroni, MSc

A.O. San Luigi Gonzaga
Orbassano, Italy
  Connect »

Michela Meroni, MSc

Fondazione IRCCS C Granda Ospedale Maggiore Policlinico Milano
Milano, Italy
  Connect »

Michela Meroni, MSc

Ospedali Riuniti Villa Cervello
Palermo, Italy
  Connect »

Michela Meroni, MSc

Hospital Universitario a Coruna
A Coruña, Spain
  Connect »

Michela Meroni, MSc

Hospital Universitario La Paz
Madrid, Spain
  Connect »

Michela Meroni, MSc

Hospital Universitario de Torrejon
Torrejón de Ardoz, Spain
  Connect »

Michela Meroni, MSc

Papworth Hospital NHS Trust
Cambridge, United Kingdom
  Connect »

Michela Meroni, MSc

Royal Infirmary of Edinburgh
Edinburgh, United Kingdom
  Connect »

Michela Meroni, MSc

Glasgow Royal Infirmary
Glasgow, United Kingdom
  Connect »

Michela Meroni, MSc

Victoria Hospital
Kirkcaldy, United Kingdom
  Connect »

Michela Meroni, MSc

Prince Philip Hospital
Llanelli, United Kingdom
  Connect »

Michela Meroni, MSc

Freeman Hospital
Newcastle upon Tyne, United Kingdom
  Connect »